Dec 16, 2020 8:30 am EST Emerald Bioscience Reports that Superior Reduction of Intraocular Pressure of its Unique Nanoemulsion Formulation of THCVHS is Published in Peer-Reviewed Journal
Dec 7, 2020 8:44 am EST Emerald Bioscience to Present at the Benzinga Global Small Cap Virtual Conference
Sep 3, 2020 11:39 am EDT Emerald Bioscience to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
Aug 13, 2020 8:30 am EDT Emerald Bioscience Appoints Biotech Veteran Dr. Margaret Dalesandro to Board of Directors
Aug 4, 2020 6:32 pm EDT Emerald Bioscience Raises approximately $7.0 Million in Upsized Registered Offering
Jul 31, 2020 9:20 am EDT Emerald Bioscience Announces Pricing of $7.0 Million Upsized Registered Offering
Jun 9, 2020 9:37 am EDT Emerald Bioscience Announces Presentation of Cannabidiol-Valine-Hemisuccinate Ocular Data at Virtual ARVO® Meeting